|16 October, 2019

Evonik Animal Nutrition to display key technologies at AGRENA 2019

Precision Livestock Farming and Ecobiol® to be showcased

Evonik Animal Nutrition to display key technologies at AGRENA 2019
  • Egyptian market very important to business
  • Company continues two decades of support for AGRENA

Cairo, Egypt. Evonik, one of the world's leading specialty chemicals companies, will be showcasing its latest animal nutrition innovations at the International Exhibition for the Administration & Production of Poultry & Livestock (AGRENA) this month. 

The company will highlight two key technologies for the livestock industry – Precision Livestock Farming and Ecobiol® - at this important regional show.

Livestock management is getting increasingly complex over time, so Evonik Animal Nutrition has developed solutions that make use of modern technologies, like sensors and software, to facilitate the process. Known as precision livestock farming (PLF), this approach goes beyond just gathering data. It combines science-based know-how with proven amino services, and innovative nutritional and health concepts. These are all embedded into specific digital solutions allowing for a better understanding of the status of the animal.

Ecobiol® is a feed additive which consists of a natural fast-growing Bacillus amyloliquefaciens CECT 5940 strain that potentially improves the overall condition of the animals and helps producers to solve quality, profitability and sustainability challenges.

“We have participated at AGRENA for the past two decades because we find it to be an excellent platform to showcase what we offer to the Egyptian Market,” said Ahmed Khater, Technical Manager GCC & MEA Gut Health Solutions at Evonik Animal Nutrition.

“The Egyptian market is very important to our business because there is an ever-growing demand on the feed industry, fueled by the rapid population growth. Evonik Animal Nutrition has shown continuous commitment to the local market since we first started selling here in the 1960s,” Khater added.

AGRENA takes place between 17th and 19th October at the Cairo International Convention and Exhibition Centre.

To learn more about the latest Evonik Animal Nutrition solutions in Egypt, please visit our booth (B 8 C Hall 1).


Company information

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.

To know more about Evonik Middle East and Africa, please visit https://mea.evonik.com/   

About Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,200 employees, and generated sales of around
€4.6 billion in 2018.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases